Requires the secretary of the executive office of health and human services to monitor and mandate changes to the price-setting practices of pharmacy benefit managers to prohibit the spread pricing payment model.
Impact
The bill, if enacted, would amend existing laws governing the Office of Health and Human Services in Rhode Island. It would empower the secretary of this office to monitor and regulate the practices of PBMs, ensuring they do not utilize spread pricing, thus promoting fairer pricing models. By implementing these changes, the state aims to better control expenditures within its Medicaid program and improve overall patient health outcomes. This legislation reflects a growing trend across various states to regulate PBM operations more rigorously to protect state-funded healthcare systems.
Summary
Bill S2462 aims to enhance the state's Medicaid program by imposing stricter regulations on pharmacy benefit managers (PBMs). The legislation seeks to address the rising prescription drug costs in Rhode Island by mandating increased transparency and accountability from PBMs. Specifically, it targets the spread pricing model, which has been criticized for allowing PBMs to profit at the expense of healthcare providers and patients. The intended outcome is to ensure that the actions of PBMs do not lead to unnecessary increases in costs for the Medicaid program and its beneficiaries.
Contention
Notable points of contention around S2462 may stem from the potential pushback from PBMs and pharmacy associations, which might argue that increased regulations could disrupt their business models. Additionally, discussions could emerge regarding the balance between regulation and innovation within the pharmaceutical market. Opponents may claim that overly restrictive regulations could hinder access to medications or lead to cost shifts to other areas of the healthcare system. Such debates are fundamental as stakeholders assess how best to balance healthcare access, provider reimbursement, and the financial sustainability of state healthcare programs.
Requires the secretary of the executive office of health and human services to monitor and mandate changes to the price-setting practices of pharmacy benefit managers to prohibit the spread pricing payment model.
Requires the secretary of the executive office of health and human services to monitor and mandate changes to the price-setting practices of pharmacy benefit managers to prohibit the spread pricing payment model.
Requires the executive office of health and human services to increase Medicaid payment rates for primary care services furnished by primary care providers to be commensurate with Medicare rates.
Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).
Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).
Requires the executive office of health and human services to apply to the Centers for Medicare and Medicaid Services for a state plan amendment for reimbursement for health services in a school.
Requires the executive office of health and human services to apply to the Centers for Medicare and Medicaid Services for a state plan amendment for reimbursement for health services in a school.